Medicare Enrolled

Dr. Jason McKellop, M.D.

Radiation Oncology · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
550 1ST AVE, New York, NY 10016
2122637300
In practice since 2009 (17 years)
NPI: 1215166657 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McKellop from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McKellop? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McKellop

Dr. Jason McKellop is a radiation oncology specialist in New York, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. McKellop performed 10,741 Medicare services across 5,047 unique beneficiaries.

Between the years covered by Open Payments, Dr. McKellop received a total of $5,035 from 1 pharmaceutical and/or device company across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McKellop is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 16% volume in NY $5,035 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,741
Medicare services
Top 16% in NY for radiation oncology
5,047
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~632 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
MRI contrast dye injection (gadoterate)
Administration of gadoterate meglumine, a contrast agent, in a 0.1 ml dose.
5,650 $0 $1
Screening mammography
An X-ray of the breast used to detect breast cancer in women who have no signs or symptoms of the disease.
1,651 $151 $296
3D screening mammography (tomosynthesis)
A screening imaging test of the breast using 3D technology to detect potential abnormalities.
1,639 $60 $250
Digital breast tomosynthesis (3D mammogram)
A specialized imaging test that creates three-dimensional pictures of the breast tissue to help detect abnormalities.
384 $47 $170
Limited ultrasound of 1 breast
A focused ultrasound examination of a single breast to evaluate specific areas of concern.
314 $80 $206
Diagnostic mammography of 1 breast
An X-ray examination of one breast to evaluate specific breast symptoms or abnormalities.
306 $113 $285
Diagnostic mammography of both breasts 242 $136 $355
Complete breast ultrasound, 1 breast
A complete ultrasound examination of one breast to visualize internal structures.
234 $131 $409
Breast biopsy with ultrasound-guided localization device placement
This procedure involves taking a tissue sample from a breast growth and placing a marker device to locate it, guided by ultrasound imaging.
88 $464 $2,032
Breast biopsy with localization device using X-ray
A procedure to remove a sample of breast tissue for testing, using X-ray guidance to place a device that marks the location of the first growth.
53 $460 $2,046
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
31 $28 $93
X-ray of surgical specimen 28 $39 $52
Breast lesion localization with ultrasound guidance
A device is placed in the breast to mark a specific growth using ultrasound guidance. This procedure helps identify the exact location of the lesion for further treatment or removal.
27 $344 $1,416
MRI scan of both breasts
A magnetic resonance imaging test that creates detailed pictures of both breasts to help evaluate breast tissue.
27 $329 $1,500
Breast biopsy with ultrasound-guided marker placement, each additional lesion
This procedure involves performing a biopsy on an additional breast growth and placing a locating device using ultrasound guidance.
22 $356 $1,630
X-ray guided placement of soft tissue locating device, first growth
This procedure involves using X-ray imaging to guide the placement of a device used to locate soft tissue, specifically for the first growth.
15 $215 $1,631
Breast lesion localization with imaging guidance
A device is placed in the breast to mark a specific area using imaging guidance. This helps locate the growth for further medical procedures.
15 $194 $737
Needle biopsy or removal of surface lymph nodes
A procedure to obtain a tissue sample or remove lymph nodes located near the surface of the body using a needle.
15 $76 $365
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$5,035
Total received (2021-2022)
Avg $2,518/year across 2 years
Top 14% in NY for radiation oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
1
Company
2
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,000 (99.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$35 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$5,000
2021
$35

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
HOLOGIC INC
$5,000
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2021-2022) ›
HOLOGIC INC
$5,035
Top 3 companies account for 100.0% of all-time payments
Associated products mentioned in payments ›
BREVERA BREAST BIOPSY SYSTEM
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (99%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a radiation oncology specialist in New York?
Compare radiation oncologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
2,025
Per 100K population
124.4
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McKellop is a mixed practice specialist, with above-average Medicare volume (top 16% in NY), with consulting-driven industry engagement in the top 14% of NY peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McKellop experienced with mri contrast dye injection (gadoterate)?
Based on Medicare claims data, Dr. McKellop performed 5,650 mri contrast dye injection (gadoterate) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McKellop receive payments from pharmaceutical companies?
Yes. Dr. McKellop received a total of $5,035 from 1 company across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McKellop's costs compare to other radiation oncologists in New York?
Dr. McKellop's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McKellop) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →